AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

USPIO Enhanced MR Imaging in CNS Tumours (UMIC)

RecruitingNAAges 16 Years - 100 YearsAllNorthern Care Alliance NHS Foundation Trust
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The immune response or inflammation is known to be a key driver of progression and growth in many solid tumours. Inflammatory cells called macrophages are present in high numbers in many brain tumours and these tumour associated macrophages or TAM are thought to have prognosis and treatment implications in these tumours. A key question, however, is how this inflammation or TAM abundance can be detected, measured and monitored in the clinic. A clinically applicable imaging test that can directly and accurately measure tumour macrophage content would be of considerable value and one technique that may provide this is USPIO enhanced magnetic resonance imaging (MRI). Following intravenous injection, USPIO or ultrasmall superparamagnetic iron oxide nanoparticles, circulate in the bloodstream before being taken up by inflammatory cells/macrophages in tumour tissue, wherein they can be detected

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Be at least 16 years old * Have a CNS tumour suspected to be one of the defined histological types (vestibular scwhannoma or low grade glioma) * Be able to lie still for up to 1 hour comfortably * Opinion of the treating clinician is that the patient will be able to successfully complete the research imaging protocol. Exclusion Criteria: * Life expectancy less than 1 year * Previous CNS radiotherapy/ stereotactic radiosurgery (SRS) * Females who are pregnant/ breastfeeding * Patients with an eGFR \< 30ml/min * Patients with known and documented history of iron overload/haemosiderosis/ haemochromatosis * Patients with immune or inflammatory conditions e.g. systemic lupus erythematous, rheumatoid arthritis * Patients with absolute (e.g. pacemaker) and relative (anxiety or claustrophobia) contraindications to MR scanning * Patients with a history of allergic reaction to iron or dextran * Patients with a history of allergic reaction to gadolinium contrast agents, asthma or renal problems * Patients who are unable to adequately understand verbal explanations or written information given in English.
๐Ÿ’Š

What it tests

  • USPIO enhanced MRI
๐Ÿ“

Where

1 site
Salford Royal Hospital Northern Care Alliance NHS Foundation Trust
Salford, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy